• Home
  • About Innovation Series
  • Innovation Series Executives
  • IVS Partners
  • Sponsorship Opportunities
  • Innovation Series Newsletter
• Innovation Series (Qld)
  • Speakers Profile
  • Sponsors
  • Future Events
  • Past Events
• Innovation Series Sydney
  • Speakers Profile
  • Sponsors
  • Future Events
  • Past Events
• Event Registration
  • Register Qld Events
  • Register Sydney Events
  • Download Registration Form
  • Sign up for Event Updates
• Media & News
  • Press Releases
  • Testimonials
  • IVS Blog
• Contact Us
  • Contact Update

Australian Institute for Commercialisation
www.ausicom.com

Dr Rowan Gilmore
Chief Executive Officer
Ph: (07) 3853 5274
Email: info@ausicom.com

The Australian Institute for Commercialisation (AIC) is a leading service organisation helping innovators achieve commercial success. Around Australia, the AIC helps business, research organisations and governments convert their ideas into successful outcomes.Using our networks and experience, we deliver services that facilitate collaboration, enhance innovation and accelerate the commercialisation of know-how and technology that our clients have created.

By providing advice, solutions and tools, and through our intermediary services, we fast-track the commercialisation of Australian innovation.Our consultancy services include:

• technology transfer facilitation and brokerage of intellectual property (IP), typically based on a market pull (rather than technology push) approach
• commercialisation project management services
• strategic advice around IP management and commercialisation
• market research and opportunity analysis
• professional development programs to increase commercialisation skills and successes.

Clients working with the AIC are able to better develop their ideas and capitalise on opportunities that create high value jobs, exports and wealth.

Davies Collison Cave
255 Elizabeth Street, Sydney
New South Wales, 2000 Australia

Chris Carter
Partner
Ph: +61 9293 1000
E: ccarter@davies.com.au
W: http://www.davies.com.au

Davies Collison Cave combines Australia’s leading patent and trade mark attorney firm and Davies Collison Cave Law, our associated intellectual property legal practice. Together we operate as a single multi-disciplinary intellectual property practice providing specialist services relating to the procuring, licensing, exploitation and enforcement of intellectual property rights. Our intellectual property expertise spans the areas of patents, trade marks, trade secrets, copyright and design protection, and related litigation and commercial transactions.

We have unrivalled expertise in all technical areas of patent law, including biotechnology, life sciences, nanotechnology, information technology, chemistry, medical devices, materials science, physics, electronics, mechanical and electrical engineering, clean technology and in trademark law. Intellectual property litigation and licensing also forms a significant part of our practice.

Davies Collison Cave continues to be Australia's largest filer of patents and trade marks and have been voted the No. 1 patent and trade mark attorney firm in Australia by Australasian Legal Business, Managing Intellectual Property and Worldleaders.

ResMed
1 Elizabeth Macarthur Drive
Bella Vista NSW 2153
Ph: 8884 1000
www.resmed.com

ResMed is a global leader in the development, manufacturing and marketing of innovative medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB).
From being an almost unknown health issue in 1989, sleep apnea is now recognized as a factor in three of the greatest health challenges facing the developed world - heart failure, stroke and type 2 diabetes. However, ResMed’s work is far from done. The SDB market continues to be vastly underpenetrated with only approximately 10% of the potential patient population receiving treatment.

SDB Snapshot
Snoring and sleep apnea are common SDB problems that can affect sleep, health and quality of life.

• About 20% of adults suffer from SDB at a level that could benefit from treatment
• Over 9O% of these are unaware of their condition and remain undiagnosed and untreated
• More than 80% of people with drug resistant hypertension have SDB
• Over 70% of type 2 diabetics suffer from sleep apnea
• Almost 70% of people who have had a stroke have SDB
• Over 70% of chronic heart failure patients experience SDB
• Approximately 77% of people who are obese, may also have SDB

ResMed also offers a range of portable homecare and hospital ventilators for adults and children with acute and chronic respiratory conditions.
As global leaders in the sleep and respiratory fields, ResMed educates and raises awareness by sharing knowledge with patients, clinicians, industry professionals and the broader medical community. The result is an ongoing journey of growth, leadership and excellence.

Macquarie University is on track to becoming one of Australia's leading research universities; it has ambitious plans to be among the top eight in Australia and one of the top 200 in the world by 2014. The university is home to some of the world’s preeminent researchers and attracts significant research funding, ranked fifth nationally based on funding, size and success rate per application. In 2009, it expanded its research capabilities through recruitment of 100 additional research staff in identified ‘concentrations of research excellence’, (COREs).

The COREs provide world-class research environments and help develop the university’s international profile. In addition, with the opening of the Macquarie University Hospital in 2010, there will be new opportunities for collaborative research projects with industry.

Medical science research
Macquarie’s Neuroscience, Vascular Sciences and Surgery team conducts research into the effects of the brain on the cardiovascular and respiratory systems; and also the effects of the cardiovascular system upon the brain. Macquarie’s current multidisciplinary team of researchers includes neuroscientists, biomedical engineers, cardiovascular specialists and surgeons. Our scope of applications is translational, from molecular biology to the bedside and operating room. Their objective is to advance knowledge in neurovascular sciences and to train graduates in specialist surgery and medicine.

Technology research
Researchers in the university’s Photonics Research Centre address fundamental questions and develop new optical technologies useful for applications such as medical diagnosis and therapy, high-resolution imaging and sensing, and micro-fabrication. The university is building a unique and cross-disciplinary team to forge innovative discoveries in quantum science and technology, which will open up new exciting routes for interdisciplinary research.
In addition, the university undertakes complementary research activities related to wireless communications, which range from transistor circuits for radios, through to issues related to telecommunications networking, digital signal processing and transmission via optical and radio propagation. This area has naturally expanded into engineering where Macquarie has concentrated its effort on a sound base of research in optics, electronics, computing and body area networks.

To find out how your business will benefit from a partnership with Macquarie researchers, contact our Enterprise Partnerships & Commercialisation team. Telephone or email Warren Bailey on 02 9805 3166
warren.bailey@mq.edu.au

Future Materials
www.future.com.au

Carla Gerbo
National Co-ordinator
Ph: (02) 9428 3777

Future Materials is a national network in which our founding partners include some of Australia's leading universities. Worldwide experience has shown that advances in materials technology often provide a real competitive advantage for many of today’s manufacturing industries. However, many companies miss out on opportunities for advancement because they simply don’t have the structures and people in place to monitor the many rapidly evolving technologies available. 

Future Materials can provide Australian companies with access to scientific equipment and personnel experienced in: Materials characterisation and evolution

Future Materials can help you solve your materials problems. A call to Future Materials could see your “possible” competitive advantage become a reality.